Aceso Life Science Group Limited (0474.HK)
HKD 0.04
(-4.88%)
HKD 0.04
(-4.88%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.97 Billion HKD | -20.21% |
| 2022 | 3.72 Billion HKD | 8.44% |
| 2021 | 3.43 Billion HKD | 9.04% |
| 2020 | 3.15 Billion HKD | 24.2% |
| 2019 | 2.53 Billion HKD | -8.42% |
| 2018 | 2.77 Billion HKD | 40.92% |
| 2017 | 1.96 Billion HKD | 10.35% |
| 2016 | 1.78 Billion HKD | 14.2% |
| 2015 | 1.56 Billion HKD | 23.06% |
| 2014 | 1.26 Billion HKD | 358.93% |
| 2013 | 276.27 Million HKD | 14.2% |
| 2012 | 241.91 Million HKD | -84.69% |
| 2011 | 1.58 Billion HKD | 67.19% |
| 2010 | 945.06 Million HKD | -32.68% |
| 2009 | 1.4 Billion HKD | 6607.16% |
| 2008 | 20.93 Million HKD | -52.76% |
| 2007 | 44.31 Million HKD | 49.58% |
| 2006 | 29.62 Million HKD | -16.5% |
| 2005 | 35.47 Million HKD | 33.88% |
| 2004 | 26.5 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q4 | 2.97 Billion HKD | 0.0% |
| 2023 Q1 | 685 Million HKD | -81.62% |
| 2023 Q2 | 3.06 Billion HKD | 347.88% |
| 2023 Q3 | 2.97 Billion HKD | -3.1% |
| 2023 FY | 2.97 Billion HKD | -20.21% |
| 2022 Q4 | 3.72 Billion HKD | 0.0% |
| 2022 Q3 | 3.72 Billion HKD | 20.97% |
| 2022 FY | 3.72 Billion HKD | 8.44% |
| 2022 Q1 | 789 Million HKD | -77.04% |
| 2022 Q2 | 3.08 Billion HKD | 290.37% |
| 2021 Q2 | 3.57 Billion HKD | 43.3% |
| 2021 FY | 3.43 Billion HKD | 9.04% |
| 2021 Q1 | 2.49 Billion HKD | -20.85% |
| 2021 Q4 | 3.43 Billion HKD | 0.0% |
| 2021 Q3 | 3.43 Billion HKD | -3.86% |
| 2020 Q3 | 3.15 Billion HKD | 20.18% |
| 2020 Q1 | 1.41 Billion HKD | -44.11% |
| 2020 FY | 3.15 Billion HKD | 24.2% |
| 2020 Q4 | 3.15 Billion HKD | 0.0% |
| 2020 Q2 | 2.62 Billion HKD | 84.91% |
| 2019 Q2 | 2.99 Billion HKD | 73.63% |
| 2019 FY | 2.53 Billion HKD | -8.42% |
| 2019 Q4 | 2.53 Billion HKD | -0.03% |
| 2019 Q3 | 2.53 Billion HKD | -15.26% |
| 2019 Q1 | 1.72 Billion HKD | -37.74% |
| 2018 Q1 | 1.41 Billion HKD | -27.84% |
| 2018 Q4 | 2.77 Billion HKD | 56.48% |
| 2018 Q3 | 1.77 Billion HKD | -31.87% |
| 2018 Q2 | 2.59 Billion HKD | 83.18% |
| 2018 FY | 2.77 Billion HKD | 40.92% |
| 2017 Q4 | 1.96 Billion HKD | 270.45% |
| 2017 FY | 1.96 Billion HKD | 10.35% |
| 2017 Q3 | 530.72 Million HKD | -59.14% |
| 2017 Q2 | 1.29 Billion HKD | 191.4% |
| 2017 Q1 | 445.73 Million HKD | -74.98% |
| 2016 Q2 | 1.42 Billion HKD | 433.66% |
| 2016 Q4 | 1.78 Billion HKD | 601.9% |
| 2016 Q3 | 253.84 Million HKD | -82.19% |
| 2016 FY | 1.78 Billion HKD | 14.2% |
| 2016 Q1 | 267.07 Million HKD | -82.88% |
| 2015 FY | 1.56 Billion HKD | 23.06% |
| 2015 Q3 | 255.84 Million HKD | -75.34% |
| 2015 Q4 | 1.56 Billion HKD | 509.84% |
| 2015 Q2 | 1.03 Billion HKD | 305.59% |
| 2015 Q1 | 255.84 Million HKD | -79.82% |
| 2014 Q2 | 850.33 Million HKD | 754.18% |
| 2014 FY | 1.26 Billion HKD | 358.93% |
| 2014 Q4 | 1.26 Billion HKD | 777.12% |
| 2014 Q1 | 99.55 Million HKD | -63.97% |
| 2014 Q3 | 144.55 Million HKD | -83.0% |
| 2013 Q4 | 276.27 Million HKD | 1873.36% |
| 2013 FY | 276.27 Million HKD | 14.2% |
| 2013 Q1 | - HKD | -100.0% |
| 2013 Q2 | 81.65 Million HKD | 0.0% |
| 2013 Q3 | 14 Million HKD | -82.86% |
| 2012 Q2 | 318.69 Million HKD | 0.0% |
| 2012 FY | 241.91 Million HKD | -84.69% |
| 2012 Q1 | - HKD | -100.0% |
| 2012 Q3 | - HKD | -100.0% |
| 2012 Q4 | 241.91 Million HKD | 0.0% |
| 2011 Q2 | 1.56 Billion HKD | 0.0% |
| 2011 Q4 | 1.58 Billion HKD | 0.0% |
| 2011 FY | 1.58 Billion HKD | 67.19% |
| 2010 Q4 | 945.06 Million HKD | 0.0% |
| 2010 Q2 | 1.21 Billion HKD | 0.0% |
| 2010 FY | 945.06 Million HKD | -32.68% |
| 2009 FY | 1.4 Billion HKD | 6607.16% |
| 2009 Q4 | 1.4 Billion HKD | 0.0% |
| 2008 FY | 20.93 Million HKD | -52.76% |
| 2007 FY | 44.31 Million HKD | 49.58% |
| 2006 FY | 29.62 Million HKD | -16.5% |
| 2005 FY | 35.47 Million HKD | 33.88% |
| 2004 FY | 26.5 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| CK Hutchison Holdings Limited | 492.92 Billion HKD | 99.397% |
| Swire Pacific Limited | 122.97 Billion HKD | 97.582% |
| Chevalier International Holdings Limited | 10.02 Billion HKD | 70.336% |
| Swire Pacific Limited | 122.97 Billion HKD | 97.582% |
| Cosmos Machinery Enterprises Limited | 1.03 Billion HKD | -187.742% |
| Kingboard Holdings Limited | 34.53 Billion HKD | 91.391% |
| EverChina Int'l Holdings Company Limited | 395.89 Million HKD | -650.949% |
| CITIC Limited | 11003.59 Billion HKD | 99.973% |
| Shanghai Industrial Holdings Limited | 101.85 Billion HKD | 97.081% |
| Beijing Enterprises Holdings Limited | 122.65 Billion HKD | 97.576% |
| AMCO United Holding Limited | 107.35 Million HKD | -2669.265% |
| EPI (Holdings) Limited | 41.64 Million HKD | -7039.427% |
| Tianjin Development Holdings Limited | 4.77 Billion HKD | 37.8% |
| Beijing Properties (Holdings) Limited | 11.66 Billion HKD | 74.524% |
| Suncorp Technologies Limited | 20.75 Million HKD | -14227.02% |
| China Public Procurement Limited | 283.05 Million HKD | -950.318% |
| Wang On Group Limited | 9.46 Billion HKD | 68.585% |
| Glory Sun Financial Group Limited | 4.54 Billion HKD | 34.571% |
| Hong Kong ChaoShang Group Limited | 43.77 Million HKD | -6691.082% |
| Meilleure Health International Industry Group Limited | 442.88 Million HKD | -571.276% |
| Altus Holdings Limited | 193.33 Million HKD | -1437.777% |
| Loco Hong Kong Holdings Limited | 347.97 Million HKD | -754.372% |